Compare Marsh & McLennan Companies, Inc. (MRSH) vs Microsoft (MSFT) Price & Performance

Marsh & McLennan (MRSH) trades at $189.13, down 0.87% on the day, with a bullish technical signal and strong fundamental performance. Recent earnings beats in Q2 2026, with EPS of $2.96 versus $2.88 expected, and 6% revenue growth highlight operational strength. The company announced the acquisition of Accel to expand its Midwest insurance reach, signaling strategic growth. Valuation metrics show a P/E of 23.35 and robust profitability with a net income margin of 14.24%.

The outlook remains positive with a consensus price target of $202.89, offering potential upside. Risks include margin pressure from rising expenses and soft P&C pricing. Institutional activity is mixed, with Bank of America reducing its stake while others like Bank of Nova Scotia increased holdings. The stock presents a solid long-term growth opportunity amid cyclical insurance sector headwinds.

Microsoft (MSFT) trades at $492.85, down 2.61% over the past day, with a bullish technical signal from moving averages. The company reported strong earnings beats in recent quarters, with Q2 2026 EPS of $4.74 exceeding the $4.24 estimate. Revenue growth remains robust, reaching $281.72 billion in 2025, while profitability metrics like a 40.31% net income margin and 34.04% ROE highlight operational strength. Recent news emphasizes Microsoft's leadership in AI and cloud computing, though concerns over capital expenditures persist.

The outlook for MSFT is positive, driven by AI integration and cloud demand, with a consensus price target of $555.00 implying ~13% upside. Risks include competitive pressures in AI, high valuation multiples, and macroeconomic volatility. Institutional sentiment is strongly bullish, with 80.49% of analysts rating it a buy, supporting a favorable long-term investment case despite near-term volatility.